Vonjo 100 mg/1
Pacritinib · CAPSULE · Sobi, Inc.
Vonjo (pacritinib) is an oral kinase inhibitor capsule used to treat myelofibrosis, a bone marrow disorder that can cause severe scarring and abnormal blood cell production. It works by blocking certain proteins involved in the disease process.
Key Facts
- Brand Name
- Vonjo
- Generic Name
- Pacritinib
- NDC Code (Product)
72482-100- Manufacturer
- Sobi, Inc.
- Strength
- 100 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA208712
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 02/28/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Vonjo used for?
Vonjo (pacritinib) is an oral kinase inhibitor capsule used to treat myelofibrosis, a bone marrow disorder that can cause severe scarring and abnormal blood cell production. It works by blocking certain proteins involved in the disease process.
Is Vonjo a controlled substance?
Vonjo is not classified as a controlled substance by the DEA.
What is the generic name for Vonjo?
The generic name for Vonjo is Pacritinib. There are no other listed brand versions of Pacritinib.
What is the NDC code for Vonjo 100 mg/1?
The NDC (National Drug Code) for Vonjo 100 mg/1 is 72482-100, listed by Sobi, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)